Please use the arrows to navigate to the sub pages
Healthcare Innovations Piece with the Mail on Sunday
TRX BioSurgery supports Premier members by offering valuable products and services that help to lower supply chain costs and improve operating efficiencies"
YORK regenerative medical company Tissue Regenix has cracked the US market, reaching the $1m sales mark for its wound care product.
Granted 510k market clearance from food and drug administration for surgipure xd
TISSUE Regenix, which uses animal and human tissue to replace damaged human body parts, said the roll out of its wound treatment DermaPure in the US market is exceeding expectations.
YORK medical device specialist Tissue Regenix has seen the world's first tendon implants completed using its technology.
Regenerative medical devices specialist Tissie Regenix has ticked another box, completing the enrolment process for its OrthoPure XM clinical trial.
@Tissue_Regenix - 5h
"Credit facilities expand cash runway to 2021"
The Tissue Regenix @HardmanandCo research note for full year 2018 ha… twitter.com/i/web/status/1…
@Tissue_Regenix - 20 Jun
If you liked Joel's article "Regenerative Medicine's Promise to Patients" (find the article link in our profile) wh… twitter.com/i/web/status/1…
@Tissue_Regenix - 18 Jun
Regenerative Medicine's Promise to Patients
Our very own President of TRX BioSurgery, Joel Pickering explains how t… twitter.com/i/web/status/1…
@Tissue_Regenix - 12 Jun
🚀NEW WEBSITE LAUNCH 🚀
We are delighted to announce the launch of our new website. Come and take a look aroundtwitter.com/i/web/status/1…07
@Tissue_Regenix - 5 Jun
Yesterday marked the release our 2018 annual results which show a top line revenue increase of 47% overall. This is… twitter.com/i/web/status/1…
You may also be interested in